Antidepressant prescriptions continue to steadily grow in England
07 Jul 2023
Biosimilar
Preview
Source: Pharmaceutical Technology
Robert Barrie
Preview
Source: Pharmaceutical Technology
There has been an overall longer-term trend of an increase in antidepressant prescriptions, with their use now up 25% compared to the 2017-18 period. Image credit: Shutterstock/Yau Ming Low
The number of antidepressant drugs being prescribed on the UK’s National Health Service (NHS) rose again, according to a quarterly report by the NHS Business Services Authority (NHSBSA).
The report, which covers the months from October 2022 to December 2022, lists the number of mental health medicines prescribed in England according to the five British National Formulary (BNF) drug groups. This includes drugs that could have been dispensed in England, Scotland, Wales, Isle of Man of the Channel Islands.
Recommended Reports
Preview
Source: Pharmaceutical Technology
ReportsLOA and PTSR Model - Amylin AgonistAmylin Agonist Long Acting GlobalData
Preview
Source: Pharmaceutical Technology
ReportsBig Data in Pharmaceuticals - Thematic Research GlobalData
View allCompanies IntelligenceNational Health ServiceGPS, L.L.C.BNF Corporation LtdView all
The British National Formulary classifies mental health medications into different groups based on their use. They are antidepressants, hypnotics and anxiolytics, central nervous system (CNS) stimulants and attention-deficit/hyperactivity disorder (ADHD) drugs, dementia medication, and antipsychotics.
In the Q3 2022-2023, period antidepressant drugs were the most prescribed drug class, totalling nearly 22 million items, a 2.67% increase compared to the same period in the previous year. The rise is part of an overall longer-term trend of an increase in antidepressant prescriptions, with their use now up 25% compared to the 2017-18 period.
The biggest percentage change in mental health medications in the last five years has been with prescriptions for CNS stimulants and ADHD drugs, in line with a gradual upward trend. Since the Q3 2017-18 period, there has been nearly a 70% increase in prescribed items in that drug class.
Dementia medication and antipsychotic prescriptions have also increased. The only downward trend in prescribing habits was seen in drugs classified as hypnotics and anxiolytics.
Mental health is a key focus of the NHS Long Term Plan, which involves an increase of funding for the sector to £2.3bn ($2.9m) per year. In addition, in January 2023, the UK government announced a further £150m ($191m) to help build mental healthcare facilities.
Amidst rising use of antidepressants and high-strength painkillers in general, the NHS issued guidance to general practitioners (GPs) to explore alternative treatments. With the aim of reducing patient reliance on such medication, GPs have been encouraged to follow a more personalised treatment plan for patients. Whilst opioid prescriptions have dropped by nearly half a million, antidepressant use is still climbing.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.